Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    15465617 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
Conditions: Hepatitis C;   Cirrhosis;   Fibrosis
Intervention: Drug: Peginterferon Alpha-2a
2 Completed
Has Results
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Conditions: Chronic Hepatitis C;   Cirrhosis, Liver;   Fibrosis, Liver;   Hepatic Cirrhosis
Interventions: Drug: Peginterferon alfa-2a + Ribavirin;   Drug: Peginterferon alfa-2a

Indicates status has not been verified in more than two years